BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 13/02/2012

FDA Clears Way for Clonidine Hydrochloride Extended-Release Tablets to be Approved via Abbreviated New Drug Applications

The FDA has determined that JENLOGA (clonidine hydrochloride) Extended-Release Tablets, 0.1 milligram and 0.2 milligram, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of these medications through abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →